Registry of Patients With Hypophosphatasia

Enrolling by invitationOBSERVATIONAL
Enrollment

1,571

Participants

Timeline

Start Date

January 20, 2015

Primary Completion Date

December 31, 2031

Study Completion Date

December 31, 2031

Conditions
Hypophosphatasia (HPP)
Trial Locations (65)

11501

Research Site, Mineola

15224

Research Site, Pittsburgh

20132

Research Site, Milan

21287

Research Site, Baltimore

22903

Research Site, Charlottesville

27710

Research Site, Durham

30033

Research Site, Decatur

33606

Research Site, Tampa

37212

Research Site, Nashville

43205

Research Site, Columbus

45229

Research Site, Cincinnati

53792

Research Site, Madison

55454

Research Site, Minneapolis

63110

Research Site, St Louis

64108

Research Site, Kansas City

80112

Research Site, Centennial

84112

Research Site, Salt Lake City

06106

Research Site, Hartford

02111

Research Site, Boston

02115

Research Site, Boston

07601

Research Site, Hackensack

Unknown

Research Site, Clayton

Research Site, Parkville

Research Site, Herston

Research Site, South Brisbane

Research Site, Linz

Research Site, Winnipeg

Research Site, Oakville

Research Site, Ottawa

Research Site, Toulouse

Research Site, Lille

Research Site, Paris

Research Site, Poitiers

Research Site, Lyon

Research Site, Paris

Research Site, Le Kremlin-Bicêtre

Research Site, Bad Reichenhall

Research Site, Würzburg

Research Site, Bochum

Research Site, Düsseldorf

Research Site, Dresden

Research Site, Berlin

Research Site, Cologne

Research Site, Giessen

Research Site, Homburg

Research Site, Mainz

Research Site, Florence

Research Site, Pisa

Research Site, Rome

Research Site, San Giovanni Rotondo

Research Site, Lodz

Research Site, Warsaw

Research Site, Riyadh

Research Site, Madrid

Research Site, Bristol

Research Site, London

Research Site, Leicester

Research Site, Stanmore

Research Site, Oxford

Research Site, Sheffield

Research Site, Dundee

Research Site, Newcastle upon Tyne

Research Site, Birmingham

Research Site, Belfast

M5G 2C4

Research Site, Toronto

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY